Company outlines path to leadership in BPH, including near-term focus on procedure growth through patient-centric solutions and increased ...
Q4 2025 earnings call recap: revenue, procedure growth, 2026 guidance, margin drivers & risks from sales changes—read now.
SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing ...
PROCEPT BioRobotics Corp. PRCT shares are down during Thursday’s premarket session following the company’s recent financial results and updates on its revenue guidance. Performance Metrics In its ...
Analysts expect PROCEPT BioRobotics to report an earnings per share (EPS) of $-0.32. PROCEPT BioRobotics bulls will hope to ...
Despite a strong demand and strategic restructuring, PROCEPT BioRobotics Corp faces short-term disruptions and financial setbacks.
Guidance assumes approximately 200 new system placements in 2026 with system ASP remaining flat to slightly up compared to 2025 levels. A one-time voluntary field action related to handpiece-system ...
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the Overlooked Small Cap Stocks to Buy Now. Wall Street is positive ...
Full-year 2025 revenue guidance was updated to approximately $323 million, reflecting 44% growth compared to 2024. This includes US system revenue of $95 million, driven by greenfield sales and some ...
Throughout the last three months, 4 analysts have evaluated PROCEPT BioRobotics (NASDAQ:PRCT), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the ...
Hosted on MSN
PROCEPT BioRobotics (PRCT): One of the Best Robotics Stocks to Buy According to Billionaires
We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands ...
In other recent news, Procept BioRobotics has seen significant financial growth, with a robust 66% year-over-year increase in revenues for the third quarter of 2024, totaling approximately $58.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results